We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Agilent Technologies Inc (A) Comm Stk US$.01

Sell:$140.71 Buy:$140.72 Change: $4.27 (2.94%)
Market closed |  Prices as at close on 12 April 2024 | Switch to live prices |
Change: $4.27 (2.94%)
Market closed |  Prices as at close on 12 April 2024 | Switch to live prices |
Change: $4.27 (2.94%)
Market closed |  Prices as at close on 12 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Agilent CrossLab segment offers services portfolio, which includes repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the laboratory operations.

Contact details

5301 Stevens Creek Blvd
United States
+1 (408) 3458886

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$42.25 billion
Shares in issue:
293.06 million
Life Sciences Tools & Services
New York Stock Exchange
United States
US dollar

Key personnel

  • Michael Mcmullen
    President, Chief Executive Officer, Director
  • Robert Mcmahon
    Chief Financial Officer, Senior Vice President
  • Michael Tang
    Senior Vice President, General Counsel, Secretary
  • Dominique Grau
    Senior Vice President - Human Resources and Global Communications
  • Henrik Ancher-Jensen
    Senior Vice President - Agilent, President - Order Fulfillment and Supply Chain
  • Philip Binns
    Senior Vice President, Agilent and President of Life Sciences and Applied Markets Group
  • Padraig Mcdonnell
    Senior Vice President, President of Agilent CrossLab
  • Rodney Gonsalves
    Chief Accounting Officer, Vice President, Corporate Controllership

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.